Pomalyst (pomalidomide) — Medica

Initial criteria

• Patient is ≥ 18 years of age
• Patient is Human Immunodeficiency Virus (HIV)-negative OR (Patient is HIV-positive AND continues to receive highly active antiretroviral therapy)

Approval duration

1 year